New hepatitis b drug tested directly in the liver
NCT ID NCT06154278
Summary
This study is testing how a new drug called Imdusiran works inside the liver of people with chronic hepatitis B. Up to 10 participants already on standard antiviral pills will receive four injections of the drug over several months and undergo two liver biopsies to measure the drug's levels and its effect on the virus. The main goal is to understand how well the drug reaches and works in the liver to control the hepatitis B infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Human Virology, University of Maryland School of Medicine
RECRUITINGBaltimore, Maryland, 21201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.